These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12021395)

  • 1. Chromaffin cell catecholamine secretion: bisindolylmaleimide compounds exhibit novel and potent antagonist effects at the nicotinic cholinergic receptor in pheochromocytoma cells.
    Mahata M; Mahapatra NR; O'Connor DT; Mahata SK
    Mol Pharmacol; 2002 Jun; 61(6):1340-7. PubMed ID: 12021395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of nicotinic responses of bovine adrenal chromaffin cells by the protein kinase C inhibitor, Ro 31-8220.
    Marley PD; Thomson KA
    Br J Pharmacol; 1996 Sep; 119(2):416-22. PubMed ID: 8886429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The chromogranin A fragment catestatin: specificity, potency and mechanism to inhibit exocytotic secretion of multiple catecholamine storage vesicle co-transmitters.
    Mahapatra NR; Mahata M; Mahata SK; O'Connor DT
    J Hypertens; 2006 May; 24(5):895-904. PubMed ID: 16612252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonism of nicotinic receptors of rat chromaffin cells by N,N, N-trimethyl-1-(4-trans-stilbenoxy)-2-propylammonium iodide: a patch clamp and ligand binding study.
    Di Angelantonio S; Nistri A; Moretti M; Clementi F; Gotti C
    Br J Pharmacol; 2000 Apr; 129(8):1771-9. PubMed ID: 10780985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist.
    Mahata SK; O'Connor DT; Mahata M; Yoo SH; Taupenot L; Wu H; Gill BM; Parmer RJ
    J Clin Invest; 1997 Sep; 100(6):1623-33. PubMed ID: 9294131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The catecholamine release-inhibitory "catestatin" fragment of chromogranin a: naturally occurring human variants with different potencies for multiple chromaffin cell nicotinic cholinergic responses.
    Mahata SK; Mahata M; Wen G; Wong WB; Mahapatra NR; Hamilton BA; O'Connor DT
    Mol Pharmacol; 2004 Nov; 66(5):1180-91. PubMed ID: 15326220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desensitization of catecholamine release. The novel catecholamine release-inhibitory peptide catestatin (chromogranin a344-364) acts at the receptor to prevent nicotinic cholinergic tolerance.
    Mahata SK; Mahata M; Parmer RJ; O'Connor DT
    J Biol Chem; 1999 Jan; 274(5):2920-8. PubMed ID: 9915830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proadrenomedullin N-terminal 20 peptide: minimal active region to regulate nicotinic receptors.
    Mahata M; Mahata SK; Parmer RJ; O'Connor DT
    Hypertension; 1998 Nov; 32(5):907-16. PubMed ID: 9822452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotinic stimulation of catecholamine synthesis and tyrosine hydroxylase phosphorylation in cervine adrenal medullary chromaffin cells.
    Knowles PJ; Douglas SA; Bunn SJ
    J Neuroendocrinol; 2011 Mar; 23(3):224-31. PubMed ID: 21121973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of nicotinic acetylcholine receptors and calcium channels by clozapine in bovine adrenal chromaffin cells.
    Park T; Bae S; Choi S; Kang B; Kim K
    Biochem Pharmacol; 2001 Apr; 61(8):1011-9. PubMed ID: 11286992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of the catecholamine release-inhibitory peptide catestatin (human chromogranin A(352-372)) with the chromaffin cell surface and Torpedo electroplax: implications for nicotinic cholinergic antagonism.
    Taupenot L; Mahata SK; Mahata M; Parmer RJ; O'Connor DT
    Regul Pept; 2000 Nov; 95(1-3):9-17. PubMed ID: 11062327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the functional subunit combination of nicotinic acetylcholine receptors in bovine adrenal chromaffin cells.
    Tachikawa E; Mizuma K; Kudo K; Kashimoto T; Yamato S; Ohta S
    Neurosci Lett; 2001 Oct; 312(3):161-4. PubMed ID: 11602335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noncompetitive inhibition by camphor of nicotinic acetylcholine receptors.
    Park TJ; Seo HK; Kang BJ; Kim KT
    Biochem Pharmacol; 2001 Apr; 61(7):787-93. PubMed ID: 11274963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catecholamine secretion in trout chromaffin cells experiencing nicotinic receptor desensitization is maintained by non-cholinergic neurotransmission.
    McNeill B; Montpetit CJ; Perry SF
    J Exp Biol; 2003 Dec; 206(Pt 23):4247-53. PubMed ID: 14581595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PKC-independent inhibition of neuronal nicotinic acetylcholine receptors by diacylglycerol.
    Andoh T; Itoh H; Higashi T; Saito Y; Ishiwa D; Kamiya Y; Yamada Y
    Brain Res; 2004 Jul; 1013(1):125-33. PubMed ID: 15196975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sigma-1 receptor ligands inhibit catecholamine secretion from adrenal chromaffin cells due to block of nicotinic acetylcholine receptors.
    Brindley RL; Bauer MB; Hartley ND; Horning KJ; Currie KPM
    J Neurochem; 2017 Oct; 143(2):171-182. PubMed ID: 28815595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of stimulus-secretion coupling in porcine adrenal chromaffin cells by receptor-mediated increases in protein kinase C activity.
    Jorgensen MS; Wagner PG; Arden WA; Jackson BA
    J Neurosci Res; 2000 Mar; 59(6):760-6. PubMed ID: 10700013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A crucial role for the mitogen-activated protein kinase pathway in nicotinic cholinergic signaling to secretory protein transcription in pheochromocytoma cells.
    Tang K; Wu H; Mahata SK; O'Connor DT
    Mol Pharmacol; 1998 Jul; 54(1):59-69. PubMed ID: 9658190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phytoestrogen cimicifugoside-mediated inhibition of catecholamine secretion by blocking nicotinic acetylcholine receptor in bovine adrenal chromaffin cells.
    Woo KC; Park YS; Jun DJ; Lim JO; Baek WY; Suh BS; Kim KT
    J Pharmacol Exp Ther; 2004 May; 309(2):641-9. PubMed ID: 14757852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteome-wide identification of cellular targets affected by bisindolylmaleimide-type protein kinase C inhibitors.
    Brehmer D; Godl K; Zech B; Wissing J; Daub H
    Mol Cell Proteomics; 2004 May; 3(5):490-500. PubMed ID: 14769951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.